Case Report
BibTex RIS Cite

A Late-Diagnosed Case of Common Variable Immunodeficiency

Year 2025, Volume: 9 Issue: 1, 122 - 127, 21.04.2025

Abstract

Common Variable Immunodeficiency (CVID) is the most common form of primary immunodeficiency (PID). CVID is characterized by decreased serum immunoglobulin levels, decreased or absent antibody production, and normal or low B-lymphocyte counts. It has a wide variety of clinical presentations, including recurring infections, inflammatory diseases, gastrointestinal diseases, lymphoid hyperplasia, granulomatous diseases, cytopenias, progressive lung diseases, and non-communicable diseases such as cancer. The main treatments are antibiotic prophylaxis and immunoglobulin replacement therapy. In this case report, a 62-year-old patient with a medical history of pneumonia that had recurred at least six times in the last five years, one of which required hospitalization, a history of pulmonary thromboembolism, and a 10-day intensive care unite stay, lymphoproliferation, and a diagnosis of CVID as a result of further examinations is presented.

References

  • 1. Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4(1):38.
  • 2. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650-1657.
  • 3. Malphettes M, Gérard L, Carmagnat M, et al. DEFI Study Group. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009;49(9):1329-1338.
  • 4. Dahl C, Petersen I, Ilkjær FV, et al. Missed Opportunities to Diagnose Common Variable Immunodeficiency: a Population-Based Case-Control Study Identifying Indicator Diseases for Common Variable Immunodeficiency. J Clin Immunol. 2023;43(8):2104-2114.
  • 5. Ozen A, Baris S, Karakoc-Aydiner E, Ozdemir C, Bahceciler NN, Barlan IB. Outcome of hypogammaglobulinemia in children: immunoglobulin levels as predictors. Clin Immunol. 2010;137(3):374-383.
  • 6. Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763-1770.
  • 7. Chapel H, Lucas M, Patel S, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol. 2012;130(5):1197-1198.
  • 8. Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep. 2009;9(5):347-352.
  • 9. Esmaeilzadeh H, Jokar-Derisi A, Hassani AH, et al. Assessment of the first presentations of common variable immunodeficiency in a large cohort of patients. BMC Immunol. 2023;24(1):9.
  • 10. Zainaldain H, Rizvi FS, Rafiemanesh H, et al. Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis. Oman Med J. 2020;35(4):157.
  • 11. Berger M, Jolles S, Orange JS, Sleasman JW. Bioavailability of IgG administered by the subcutaneous route. J Clin Immunol. 2013;33(5):984-990.

Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu

Year 2025, Volume: 9 Issue: 1, 122 - 127, 21.04.2025

Abstract

Yaygın Değişken İmmün Yetmezlik (YDİY) primer immün yetmezliklerin (PIY) en yaygın formudur. YDİY azalmış serum immünoglobulin seviyeleri, azalmış antikor üretimi veya spesifik antikor üretiminin olmaması ve normal veya düşük B-lenfosit sayımları ile karakterizedir. Sık tekrarlayan enfeksiyonlar ve otoimmünite, gastrointestinal inflamatuar hastalık, karaciğer hastalığı, lenfoid hiperplazi, granülomatöz hastalık, sitopeniler, ilerleyici akciğer hastalığı ve kanser gibi enfeksiyöz olmayan komplikasyonlar dahil olmak üzere geniş bir klinik sunum yelpazesine sahiptir. Temel tedavileri antibiyotik profilaksisi ve immünoglobulin replasman tedavisidir. Bu olgu sunumunda 62 yaşında; ayrıntılı immunoloji sorgulamasında son beş senedir en az altı kere tekrarlamış olan biri yatış gerektiren pnömoni hikayesi, pulmoner tromboemboli öyküsü ile 10 gün yoğun bakım ünitesinde yatışı, lenfoproliferasyonu olan ve ileri tetkikler sonucunda YDİY tanısı alan bir olgu sunulmuştur.

References

  • 1. Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4(1):38.
  • 2. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650-1657.
  • 3. Malphettes M, Gérard L, Carmagnat M, et al. DEFI Study Group. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009;49(9):1329-1338.
  • 4. Dahl C, Petersen I, Ilkjær FV, et al. Missed Opportunities to Diagnose Common Variable Immunodeficiency: a Population-Based Case-Control Study Identifying Indicator Diseases for Common Variable Immunodeficiency. J Clin Immunol. 2023;43(8):2104-2114.
  • 5. Ozen A, Baris S, Karakoc-Aydiner E, Ozdemir C, Bahceciler NN, Barlan IB. Outcome of hypogammaglobulinemia in children: immunoglobulin levels as predictors. Clin Immunol. 2010;137(3):374-383.
  • 6. Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763-1770.
  • 7. Chapel H, Lucas M, Patel S, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol. 2012;130(5):1197-1198.
  • 8. Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep. 2009;9(5):347-352.
  • 9. Esmaeilzadeh H, Jokar-Derisi A, Hassani AH, et al. Assessment of the first presentations of common variable immunodeficiency in a large cohort of patients. BMC Immunol. 2023;24(1):9.
  • 10. Zainaldain H, Rizvi FS, Rafiemanesh H, et al. Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis. Oman Med J. 2020;35(4):157.
  • 11. Berger M, Jolles S, Orange JS, Sleasman JW. Bioavailability of IgG administered by the subcutaneous route. J Clin Immunol. 2013;33(5):984-990.
There are 11 citations in total.

Details

Primary Language Turkish
Subjects Infectious Diseases, Chest Diseases
Journal Section Case Reports
Authors

Coşkun Doğan 0000-0002-6948-5187

Nurhan Kasap 0000-0001-5432-4076

Cihan Örçen 0000-0003-1047-2004

Early Pub Date April 16, 2025
Publication Date April 21, 2025
Submission Date October 6, 2024
Acceptance Date January 28, 2025
Published in Issue Year 2025 Volume: 9 Issue: 1

Cite

APA Doğan, C., Kasap, N., & Örçen, C. (2025). Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu. Ahi Evran Medical Journal, 9(1), 122-127.
AMA Doğan C, Kasap N, Örçen C. Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu. Ahi Evran Med J. April 2025;9(1):122-127.
Chicago Doğan, Coşkun, Nurhan Kasap, and Cihan Örçen. “Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu”. Ahi Evran Medical Journal 9, no. 1 (April 2025): 122-27.
EndNote Doğan C, Kasap N, Örçen C (April 1, 2025) Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu. Ahi Evran Medical Journal 9 1 122–127.
IEEE C. Doğan, N. Kasap, and C. Örçen, “Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu”, Ahi Evran Med J, vol. 9, no. 1, pp. 122–127, 2025.
ISNAD Doğan, Coşkun et al. “Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu”. Ahi Evran Medical Journal 9/1 (April 2025), 122-127.
JAMA Doğan C, Kasap N, Örçen C. Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu. Ahi Evran Med J. 2025;9:122–127.
MLA Doğan, Coşkun et al. “Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu”. Ahi Evran Medical Journal, vol. 9, no. 1, 2025, pp. 122-7.
Vancouver Doğan C, Kasap N, Örçen C. Geç Yaşta Tanı Alan Yaygın Değişken İmmün Yetmezlik Olgusu. Ahi Evran Med J. 2025;9(1):122-7.

Ahi Evran Medical Journal  is indexed in ULAKBIM TR Index, Turkish Medline, DOAJ, Index Copernicus, EBSCO and Turkey Citation Index. Ahi Evran Medical Journal is periodical scientific publication. Can not be cited without reference. Responsibility of the articles belong to the authors.

    Creative Commons Lisansı

This journal is licensed under the Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı.